ONKOTEV Score (Cancer-Associated VTE Risk)
ONKOTEV Score (Cancer-Associated VTE Risk) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the ONKOTEV Score (Cancer-Associated VTE Risk) → Runs in your browser. No signup, no tracking.
What this is
ONKOTEV Score (Cancer-Associated VTE Risk) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. ONKOTEV Score (Cancer-Associated VTE Risk) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Cella CA, Di Minno G, Carlomagno C, et al. Preventing venous thromboembolism in ambulatory cancer patients: the ONKOTEV study. Oncologist. 2017;22(5):601-608. Read the source ↗
Worked example: ONKOTEV score 2 — high 6-month VTE risk.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.